首页 > 最新文献

DARU Journal of Pharmaceutical Sciences最新文献

英文 中文
Toxicological effect of acetaminophen, metamizole, and nimesulide cocktail on early development of zebrafish. 对乙酰氨基酚、甲咪唑和尼美舒利鸡尾酒对斑马鱼早期发育的毒理影响
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-07-11 DOI: 10.1007/s40199-024-00528-9
Wellington Fernandes de Carvalho, Ednalva de Souza Pereira Lima, Whocely Victor de Castro, Ralph Gruppi Thomé, Hélio Batista Santos

Background: Several countries' most incorrectly discarded medicines are acetaminophen (ACM), metamizole (MTZ), and nimesulide (NMS). These xenobiotics easily reach the aquatic environment; such contamination is very important for the health of humans and other species, yet little explored.

Objectives: To evaluate the cocktail effect of ACM, MTZ, and NMS during zebrafish's initial development.

Methods: Zebrafish embryos 6-8 h post-fertilization (hpf) were exposed to different concentrations of ACM, MTZ, and NMS, separately, to obtain the 50% lethal concentrations (LC50). Next, the embryos were exposed to distinct concentrations of the cocktail (LC50/2, LC50/5, LC50/10, and LC50/20) in a semi-static system. Samples were analyzed 0, 24, 48, and 96 h after exposure, and the drugs' concentrations in E3 medium were assessed by high-performance liquid chromatography. For embryotoxicity evaluation, the mortality, hatching, and heart rates; total length; and pericardial and yolk sac areas were determined. In addition, body malformations, edemas, presence of pigmentation, and histopathological assessments were also recorded.

Results: The LC50 values obtained for MTZ, ACM, and NMS were 4.69 mgmL-1, 799.98 μgmL-1, and 0.92 μgmL-1, respectively. No difference was observed between the drugs' nominal and observed concentrations at each time point. The cocktail significantly induced mortality and decreased hatching in the LC50/10, LC50/5, and LC50/2 groups. Additionally, body malformations, pigmentation loss, and yolk sac and pericardial edemas were observed in the cocktail groups. The cocktail groups' larvae had decreased total length and slower heart rates compared to the controls (p < 0.05). The histopathological assessment showed that yolk sac edema promoted severe histological changes in the esophageal-intestine junction and intestine in larvae treated with cocktails. Moreover, PAS-positive structures decreased in the esophageal-intestine junction, intestine, and liver in larvae exposed to pharmaceutical cocktails.

Conclusion: This study's findings suggest the cocktail of ACM, MTZ, and NMS may be hazardous to aquatic organisms in case of environmental contamination.

背景:一些国家最常错误丢弃的药物是对乙酰氨基酚(ACM)、甲咪唑(MTZ)和尼美舒利(NMS)。这些异生物体很容易进入水生环境;这种污染对人类和其他物种的健康非常重要,但却很少有人对其进行研究:评估 ACM、MTZ 和 NMS 在斑马鱼初始发育过程中的鸡尾酒效应:方法:将受精后 6-8 小时的斑马鱼胚胎分别暴露于不同浓度的 ACM、MTZ 和 NMS,以获得 50% 的致死浓度(LC50)。然后,在半静态系统中将胚胎暴露于不同浓度的鸡尾酒(LC50/2、LC50/5、LC50/10 和 LC50/20)中。暴露后 0、24、48 和 96 小时对样本进行分析,并通过高效液相色谱法评估 E3 培养基中的药物浓度。在胚胎毒性评估方面,测定了死亡率、孵化率和心脏率;总长度;心包和卵黄囊面积。此外,还记录了身体畸形、水肿、色素沉着和组织病理学评估结果:MTZ、ACM和NMS的半数致死浓度分别为4.69 mgmL-1、799.98 μgmL-1和0.92 μgmL-1。在每个时间点,药物的标称浓度与观察浓度之间没有差异。在 LC50/10、LC50/5 和 LC50/2 组中,鸡尾酒能明显诱导死亡并降低孵化率。此外,在鸡尾酒组中还观察到身体畸形、色素脱失、卵黄囊和心包水肿。与对照组相比,鸡尾酒组幼虫的总长度减少,心率减慢(p 结论:鸡尾酒组幼虫的总长度和心率均低于对照组:本研究结果表明,ACM、MTZ 和 NMS 鸡尾酒可能会在环境污染的情况下对水生生物造成危害。
{"title":"Toxicological effect of acetaminophen, metamizole, and nimesulide cocktail on early development of zebrafish.","authors":"Wellington Fernandes de Carvalho, Ednalva de Souza Pereira Lima, Whocely Victor de Castro, Ralph Gruppi Thomé, Hélio Batista Santos","doi":"10.1007/s40199-024-00528-9","DOIUrl":"10.1007/s40199-024-00528-9","url":null,"abstract":"<p><strong>Background: </strong>Several countries' most incorrectly discarded medicines are acetaminophen (ACM), metamizole (MTZ), and nimesulide (NMS). These xenobiotics easily reach the aquatic environment; such contamination is very important for the health of humans and other species, yet little explored.</p><p><strong>Objectives: </strong>To evaluate the cocktail effect of ACM, MTZ, and NMS during zebrafish's initial development.</p><p><strong>Methods: </strong>Zebrafish embryos 6-8 h post-fertilization (hpf) were exposed to different concentrations of ACM, MTZ, and NMS, separately, to obtain the 50% lethal concentrations (LC<sub>50</sub>). Next, the embryos were exposed to distinct concentrations of the cocktail (LC<sub>50</sub>/2, LC<sub>50</sub>/5, LC<sub>50</sub>/10, and LC<sub>50</sub>/20) in a semi-static system. Samples were analyzed 0, 24, 48, and 96 h after exposure, and the drugs' concentrations in E3 medium were assessed by high-performance liquid chromatography. For embryotoxicity evaluation, the mortality, hatching, and heart rates; total length; and pericardial and yolk sac areas were determined. In addition, body malformations, edemas, presence of pigmentation, and histopathological assessments were also recorded.</p><p><strong>Results: </strong>The LC<sub>50</sub> values obtained for MTZ, ACM, and NMS were 4.69 mgmL<sup>-1</sup>, 799.98 μgmL<sup>-1</sup>, and 0.92 μgmL<sup>-1</sup>, respectively. No difference was observed between the drugs' nominal and observed concentrations at each time point. The cocktail significantly induced mortality and decreased hatching in the LC<sub>50</sub>/10, LC<sub>50</sub>/5, and LC<sub>50</sub>/2 groups. Additionally, body malformations, pigmentation loss, and yolk sac and pericardial edemas were observed in the cocktail groups. The cocktail groups' larvae had decreased total length and slower heart rates compared to the controls (p < 0.05). The histopathological assessment showed that yolk sac edema promoted severe histological changes in the esophageal-intestine junction and intestine in larvae treated with cocktails. Moreover, PAS-positive structures decreased in the esophageal-intestine junction, intestine, and liver in larvae exposed to pharmaceutical cocktails.</p><p><strong>Conclusion: </strong>This study's findings suggest the cocktail of ACM, MTZ, and NMS may be hazardous to aquatic organisms in case of environmental contamination.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"585-597"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication. COVID-19 疗法的抗药性和副作用的合理机制:根除该疾病的瓶颈。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-07-19 DOI: 10.1007/s40199-024-00524-z
Swarnali Das, Sreyashi Nath, Shahjahan, Sanjay Kumar Dey

Background: COVID-19 pandemic has turned our world upside down by meddling with our normal lives. While there is no definitive drug against SARS-CoV-2, antiviral drugs that are already in the market, are being repurposed against it, could now complete long-term as well as all age-specific investigations, and they are successful in saving millions of lives. Nevertheless, side-effects are emergingly seen in the patients undergoing treatment, and ineffectiveness is increasingly found due to the emerging notorious variants of the virus. Many of them are also facing serious co-infections including black fungus, Zika, and H1N1 virus to name a few.

Objectives: Therefore, this review highlights both drug resistance, their side-effects, and the significance for proper and long-term clinical trials of all age groups including children.

Methods: We have explored and proposed the mechanisms of drug resistance that may arise due to the misuse or overuse of drugs based on available experimental reports.

Results: The review provides solutions to the aforesaid issues of drug-resistance and side-effects by providing combination therapies, ancillary treatments, and other preventive strategies that can be useful in preventing drawbacks thereby curbing COVID-19 or similar future infections to maintain our normal lives.

Conclusion: COVID-19 and its long-term effects, if any, can be eradicated with strategic and mindful use of related therapeutics in a controlled manner.

背景介绍COVID-19 大流行扰乱了我们的正常生活,使我们的世界发生了翻天覆地的变化。虽然目前还没有针对 SARS-CoV-2 的特效药物,但市场上已有的抗病毒药物正在被重新用于治疗 SARS-CoV-2,它们现在可以完成长期和所有特定年龄段的研究,并成功挽救了数百万人的生命。然而,在接受治疗的患者中,副作用不断出现,而且由于新出现的臭名昭著的病毒变种,无效的情况也越来越多。他们中的许多人还面临着严重的合并感染,包括黑木耳、寨卡病毒和 H1N1 病毒等等:因此,这篇综述强调了耐药性、其副作用以及对包括儿童在内的所有年龄组进行适当和长期临床试验的意义:方法:我们根据现有的实验报告,探讨并提出了滥用或过度使用药物可能导致的耐药性机制:结果:综述通过提供联合疗法、辅助治疗和其他预防策略,为上述耐药性和副作用问题提供了解决方案,这些策略可以有效预防弊端,从而遏制 COVID-19 或类似的未来感染,维持我们的正常生活:结论:通过有控制地战略性使用相关疗法,可以根除 COVID-19 及其长期影响(如果有的话)。
{"title":"Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication.","authors":"Swarnali Das, Sreyashi Nath, Shahjahan, Sanjay Kumar Dey","doi":"10.1007/s40199-024-00524-z","DOIUrl":"10.1007/s40199-024-00524-z","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 pandemic has turned our world upside down by meddling with our normal lives. While there is no definitive drug against SARS-CoV-2, antiviral drugs that are already in the market, are being repurposed against it, could now complete long-term as well as all age-specific investigations, and they are successful in saving millions of lives. Nevertheless, side-effects are emergingly seen in the patients undergoing treatment, and ineffectiveness is increasingly found due to the emerging notorious variants of the virus. Many of them are also facing serious co-infections including black fungus, Zika, and H1N1 virus to name a few.</p><p><strong>Objectives: </strong>Therefore, this review highlights both drug resistance, their side-effects, and the significance for proper and long-term clinical trials of all age groups including children.</p><p><strong>Methods: </strong>We have explored and proposed the mechanisms of drug resistance that may arise due to the misuse or overuse of drugs based on available experimental reports.</p><p><strong>Results: </strong>The review provides solutions to the aforesaid issues of drug-resistance and side-effects by providing combination therapies, ancillary treatments, and other preventive strategies that can be useful in preventing drawbacks thereby curbing COVID-19 or similar future infections to maintain our normal lives.</p><p><strong>Conclusion: </strong>COVID-19 and its long-term effects, if any, can be eradicated with strategic and mindful use of related therapeutics in a controlled manner.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"801-823"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population Pharmacokinetics of Loxoprofen and its alcoholic metabolites in healthy Korean men. 健康韩国男性体内洛索洛芬及其酒精代谢物的群体药代动力学。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-08-15 DOI: 10.1007/s40199-024-00533-y
Ji-Hun Jang, Ho-Suk Kang, Seung-Hyun Jeong
<p><strong>Background: </strong>Loxoprofen has been actively used clinically to relieve musculoskeletal pain and inflammatory symptoms. However, there are few reports on quantitative pharmacokinetic (PK) prediction tools and diversity analyzes for loxoprofen within populations.</p><p><strong>Objectives: </strong>The aim of this study was to identify effective covariates associated with explaining inter-individual PK variability through a population pharmacokinetic (Pop-PK) modeling approach for loxoprofen, and to provide a starting point for establishing scientific dosing regimens.</p><p><strong>Method: </strong>The bioequivalence PK results of loxoprofen performed on 52 healthy Korean men and the physiological and biochemical parameters derived from each individual were used as base data for the development of a Pop-PK model of loxoprofen. In order to simultaneously predict the PKs of the active form according to loxoprofen exposure, previously reported PK results of trans-alcohol loxoprofen, an active metabolite of loxoprofen, were used to expand the model.</p><p><strong>Results: </strong>The Pop-PK profiles of loxoprofen were described in terms of the basic structure of a non-sequential two absorption with 2-disposition compartment, and for inter-individual PK variations, peripheral compartment volume of distribution could be correlated with body surface area (BSA), and central compartment clearance with creatinine clearance (CrCL) and albumin levels. As a result of the model simulation, the concentrations of loxoprofen and its alcoholic metabolites in plasma significantly decreased as CrCL and albumin levels increased and decreased, respectively. On the other hand, it was confirmed that the higher the BSA, the greater the distribution of loxoprofen to the periphery, and the minimum concentrations of loxoprofen and alcoholic metabolites in plasma in steady-state increased by approximately 1.78-2 times, while the fluctuation between maximum and minimum concentrations decreased. The results suggest that patients with large BSA, impaired renal function, and high serum albumin levels may have significantly higher plasma exposure to loxoprofen and trans-alcohol loxoprofen. It was also suggested that the potential side effects in the gastrointestinal system and various tissues and the level of exposure in plasma due to long-term application of loxoprofen in this patient group could be causally explained.</p><p><strong>Conclusion: </strong>This study provides a very useful starting point for a scientific precision medicine approach to loxoprofen by discovering effective covariates and establishing a quantitative model that can explain the diversity of loxoprofen PKs within the population.</p><p><strong>Clinical trial registration: </strong>The clinical study protocol used in this study was thoroughly reviewed and approved by the Institutional Review Board of the Institute of Bioequivalence and Bridging Study, Chonnam National University, Gwangju, Rep
背景:洛索洛芬在临床上被积极用于缓解肌肉骨骼疼痛和炎症症状。然而,有关洛索洛芬在人群中的定量药代动力学(PK)预测工具和多样性分析的报道很少:本研究旨在通过群体药代动力学(Pop-PK)建模方法确定与解释洛索洛芬个体间 PK 变异性相关的有效协变量,并为制定科学的给药方案提供一个起点:方法:以对 52 名健康韩国男性进行的洛索洛芬生物等效 PK 结果和每个人的生理生化参数为基础数据,建立洛索洛芬的 Pop-PK 模型。为了根据洛索洛芬的暴露情况同时预测其活性形式的 PK,我们使用了之前报告的洛索洛芬的活性代谢产物反式酒精洛索洛芬的 PK 结果来扩展模型:结果:洛索洛芬的Pop-PK曲线是用一个非连续的2吸收2分配区室的基本结构来描述的,对于个体间的PK变化,外周区室的分配体积与体表面积(BSA)相关,中心区室的清除率与肌酐清除率(CrCL)和白蛋白水平相关。模型模拟结果表明,随着 CrCL 和白蛋白水平的升高和降低,血浆中洛索洛芬及其酒精代谢物的浓度明显降低。另一方面,研究证实,BSA 越高,洛索洛芬向外周的分布越多,血浆中洛索洛芬及其酒精代谢物的最低浓度在稳态时增加了约 1.78-2 倍,而最高浓度和最低浓度之间的波动则减小了。结果表明,BSA 大、肾功能受损和血清白蛋白水平高的患者,其血浆中洛索洛芬和反式酒精洛索洛芬的暴露量可能会明显增加。该研究还认为,胃肠道系统和各种组织的潜在副作用以及血浆中洛索洛芬的暴露水平可能与该患者群体长期应用洛索洛芬有因果关系:本研究为洛索洛芬的科学精准医疗方法提供了一个非常有用的起点,它发现了有效的协变量并建立了一个定量模型,该模型可以解释人群中洛索洛芬PK的多样性:本研究中使用的临床研究方案已通过大韩民国光州全南国立大学生物等效性和衔接研究研究所机构审查委员会的全面审查和批准。生物等效性研究许可证编号如下:041113; 10.15.2004.
{"title":"Population Pharmacokinetics of Loxoprofen and its alcoholic metabolites in healthy Korean men.","authors":"Ji-Hun Jang, Ho-Suk Kang, Seung-Hyun Jeong","doi":"10.1007/s40199-024-00533-y","DOIUrl":"10.1007/s40199-024-00533-y","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Loxoprofen has been actively used clinically to relieve musculoskeletal pain and inflammatory symptoms. However, there are few reports on quantitative pharmacokinetic (PK) prediction tools and diversity analyzes for loxoprofen within populations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The aim of this study was to identify effective covariates associated with explaining inter-individual PK variability through a population pharmacokinetic (Pop-PK) modeling approach for loxoprofen, and to provide a starting point for establishing scientific dosing regimens.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt;The bioequivalence PK results of loxoprofen performed on 52 healthy Korean men and the physiological and biochemical parameters derived from each individual were used as base data for the development of a Pop-PK model of loxoprofen. In order to simultaneously predict the PKs of the active form according to loxoprofen exposure, previously reported PK results of trans-alcohol loxoprofen, an active metabolite of loxoprofen, were used to expand the model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The Pop-PK profiles of loxoprofen were described in terms of the basic structure of a non-sequential two absorption with 2-disposition compartment, and for inter-individual PK variations, peripheral compartment volume of distribution could be correlated with body surface area (BSA), and central compartment clearance with creatinine clearance (CrCL) and albumin levels. As a result of the model simulation, the concentrations of loxoprofen and its alcoholic metabolites in plasma significantly decreased as CrCL and albumin levels increased and decreased, respectively. On the other hand, it was confirmed that the higher the BSA, the greater the distribution of loxoprofen to the periphery, and the minimum concentrations of loxoprofen and alcoholic metabolites in plasma in steady-state increased by approximately 1.78-2 times, while the fluctuation between maximum and minimum concentrations decreased. The results suggest that patients with large BSA, impaired renal function, and high serum albumin levels may have significantly higher plasma exposure to loxoprofen and trans-alcohol loxoprofen. It was also suggested that the potential side effects in the gastrointestinal system and various tissues and the level of exposure in plasma due to long-term application of loxoprofen in this patient group could be causally explained.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study provides a very useful starting point for a scientific precision medicine approach to loxoprofen by discovering effective covariates and establishing a quantitative model that can explain the diversity of loxoprofen PKs within the population.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical trial registration: &lt;/strong&gt;The clinical study protocol used in this study was thoroughly reviewed and approved by the Institutional Review Board of the Institute of Bioequivalence and Bridging Study, Chonnam National University, Gwangju, Rep","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"631-648"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public interest in drug-related problems reflected in information search trends: an infodemiological study. 信息搜索趋势所反映的公众对毒品相关问题的兴趣:一项信息空间学研究。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-06-18 DOI: 10.1007/s40199-024-00519-w
Laura Martínez-Aguilar, María Sanz-Lorente, Fernando Martínez-Martínez, María J Faus, Javier Sanz-Valero

Background: The analysis of how people search and "navigate" the internet to obtain health-related information and how they communicate and share this information can provide valuable knowledge about the disease patterns behaviour and health habits of populations.

Objective: To determine the population's interest in drug-related problems through information search trends.

Method: A descriptive ecological correlational study, based on obtaining Google Trends data.

Variables studied: relative search volume (RSV), evolution over time, milestones and seasonality.

Results: The most searched topic was drug overdose, with mean RSV of 56.25 ± 0.65. The highest increase occurred in the contraindication topic (R2 = 0.87, p < 0.001). The main milestone was observed in the drug overdose topic in July 2018 (RSV = 100). A very close relationship was found between adverse drug reaction and contraindication (R = 0.89, p < 0.001). Slight seasonality was noted in the adverse drug reaction (augmented Dickey-Fuller test [ADF] = -1.96), contraindication (ADF = -2.66) and drug interaction (ADF = -1.67) topics, but did not show an epidemiological trend.

Conclusions: The greatest public interest was found in the drug overdose and contraindication topics, which showed a stronger upward trend, although the seasonality study did not show any very notable data or demonstrate epidemiological information search behaviour. The main milestone observed was due to media factors related to the consumption of narcotics. There was a clear difference in English-speaking countries in the use of the drug overdose topic. A correlation between the adverse drug reaction and contraindication topics was confirmed.

背景:分析人们如何搜索和 "浏览 "互联网以获取与健康有关的信息,以及他们如何交流和分享这些信息,可以为了解人群的疾病模式行为和健康习惯提供有价值的知识:通过信息搜索趋势确定人们对毒品相关问题的兴趣:研究变量:相对搜索量(RSV)、随时间的演变、里程碑和季节性:搜索次数最多的主题是药物过量,平均 RSV 为 56.25 ± 0.65。禁忌症主题的搜索量增幅最大(R2 = 0.87,p):尽管季节性研究没有显示任何非常显著的数据或流行病学信息搜索行为,但公众对药物过量和禁忌症主题的兴趣最大,这两个主题显示出更强的上升趋势。观察到的主要里程碑是与麻醉品消费有关的媒体因素。英语国家在使用药物过量话题方面存在明显差异。药物不良反应和禁忌话题之间的相关性得到了证实。
{"title":"Public interest in drug-related problems reflected in information search trends: an infodemiological study.","authors":"Laura Martínez-Aguilar, María Sanz-Lorente, Fernando Martínez-Martínez, María J Faus, Javier Sanz-Valero","doi":"10.1007/s40199-024-00519-w","DOIUrl":"10.1007/s40199-024-00519-w","url":null,"abstract":"<p><strong>Background: </strong>The analysis of how people search and \"navigate\" the internet to obtain health-related information and how they communicate and share this information can provide valuable knowledge about the disease patterns behaviour and health habits of populations.</p><p><strong>Objective: </strong>To determine the population's interest in drug-related problems through information search trends.</p><p><strong>Method: </strong>A descriptive ecological correlational study, based on obtaining Google Trends data.</p><p><strong>Variables studied: </strong>relative search volume (RSV), evolution over time, milestones and seasonality.</p><p><strong>Results: </strong>The most searched topic was drug overdose, with mean RSV of 56.25 ± 0.65. The highest increase occurred in the contraindication topic (R<sup>2</sup> = 0.87, p < 0.001). The main milestone was observed in the drug overdose topic in July 2018 (RSV = 100). A very close relationship was found between adverse drug reaction and contraindication (R = 0.89, p < 0.001). Slight seasonality was noted in the adverse drug reaction (augmented Dickey-Fuller test [ADF] = -1.96), contraindication (ADF = -2.66) and drug interaction (ADF = -1.67) topics, but did not show an epidemiological trend.</p><p><strong>Conclusions: </strong>The greatest public interest was found in the drug overdose and contraindication topics, which showed a stronger upward trend, although the seasonality study did not show any very notable data or demonstrate epidemiological information search behaviour. The main milestone observed was due to media factors related to the consumption of narcotics. There was a clear difference in English-speaking countries in the use of the drug overdose topic. A correlation between the adverse drug reaction and contraindication topics was confirmed.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"537-547"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141418206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study. 含有富马酸二甲酯和苯并噻唑支架的混合衍生物用于多发性硬化症的潜在治疗;硅学和体内研究。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-08-06 DOI: 10.1007/s40199-024-00529-8
Seyedeh Azin Mirmotahari, Mehdi Aliomrani, Farshid Hassanzadeh, Hajar Sirous, Mahboubeh Rostami

Background: Multiple Sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the CNS. Riluzole and dimethyl fumarate (DMF) are two FDA-approved drugs to treat amyotrophic lateral sclerosis (ALS) and MS. Riluzole (a benzothiazole derivative) inhibits glutamate release from nerve terminals by antagonizing the N-Methyl-D-Aspartate (NMDA) receptor, and DMF upregulates anti-oxidative pathways.

Objectives: Herein, using molecular hybridization strategy, we synthesized some new hybrid structures of Riluzole and DMF through some common successive synthetic pathways for evaluating their potential activity for remyelination in MS treatment.

Methods: Molecular docking experiments assessed the binding affinity of proposed structures to the NMDA active site. The designed structures were synthesized and purified based on well-known chemical synthesis procedures. Afterward, in vivo evaluation for their activity was done in the C57Bl/6 Cuprizone-induced demyelination MS model.

Results and conclusion: The proposed derivatives were recognized to be potent enough based on docking studies (ΔGbind of all derivatives were -7.2 to -7.52 compare to the Ifenprodil (-6.98) and Riluzole (-4.42)). The correct structures of desired derivatives were confirmed using spectroscopic methods. Based on in vivo studies, D4 and D6 derivatives exhibited the best pharmacological results, although only D6 showed a statistically significant difference compared to the control. Also, for D4 and D6 derivatives, myelin staining confirmed reduced degeneration in the corpus callosum. Consequently, D4 and D6 derivatives are promising candidates for developing new NMDA antagonists with therapeutic value against MS disorders.

背景:多发性硬化症(MS)是一种慢性自身免疫性中枢神经系统炎症性疾病。利鲁唑和富马酸二甲酯(DMF)是美国食品及药物管理局批准的两种治疗肌萎缩侧索硬化症(ALS)和多发性硬化症的药物。利鲁唑(一种苯并噻唑衍生物)通过拮抗 N-甲基-D-天冬氨酸(NMDA)受体抑制神经末梢释放谷氨酸,而 DMF 则能上调抗氧化途径:在此,我们采用分子杂交策略,通过一些常见的连续合成途径合成了一些新的利鲁唑和DMF杂交结构,以评估它们在多发性硬化症治疗中再髓鞘化的潜在活性:分子对接实验评估了拟议结构与 NMDA 活性位点的结合亲和力。根据著名的化学合成程序合成和纯化所设计的结构。随后,在 C57Bl/6 Cuprizone 诱导的脱髓鞘 MS 模型中对其活性进行了体内评价:根据对接研究(与艾芬地尔(-6.98)和利鲁唑(-4.42)相比,所有衍生物的ΔGbind值为-7.2至-7.52),确认了所提出的衍生物具有足够的效力。利用光谱方法确认了所需衍生物的正确结构。根据体内研究,D4 和 D6 衍生物的药理效果最好,但只有 D6 与对照组相比有显著的统计学差异。此外,D4 和 D6 衍生物的髓鞘染色证实了胼胝体退化的减少。因此,D4 和 D6 衍生物有望成为开发新的 NMDA 拮抗剂的候选药物,对多发性硬化症具有治疗价值。
{"title":"Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study.","authors":"Seyedeh Azin Mirmotahari, Mehdi Aliomrani, Farshid Hassanzadeh, Hajar Sirous, Mahboubeh Rostami","doi":"10.1007/s40199-024-00529-8","DOIUrl":"10.1007/s40199-024-00529-8","url":null,"abstract":"<p><strong>Background: </strong>Multiple Sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the CNS. Riluzole and dimethyl fumarate (DMF) are two FDA-approved drugs to treat amyotrophic lateral sclerosis (ALS) and MS. Riluzole (a benzothiazole derivative) inhibits glutamate release from nerve terminals by antagonizing the N-Methyl-D-Aspartate (NMDA) receptor, and DMF upregulates anti-oxidative pathways.</p><p><strong>Objectives: </strong>Herein, using molecular hybridization strategy, we synthesized some new hybrid structures of Riluzole and DMF through some common successive synthetic pathways for evaluating their potential activity for remyelination in MS treatment.</p><p><strong>Methods: </strong>Molecular docking experiments assessed the binding affinity of proposed structures to the NMDA active site. The designed structures were synthesized and purified based on well-known chemical synthesis procedures. Afterward, in vivo evaluation for their activity was done in the C57Bl/6 Cuprizone-induced demyelination MS model.</p><p><strong>Results and conclusion: </strong>The proposed derivatives were recognized to be potent enough based on docking studies (ΔG<sub>bind</sub> of all derivatives were -7.2 to -7.52 compare to the Ifenprodil (-6.98) and Riluzole (-4.42)). The correct structures of desired derivatives were confirmed using spectroscopic methods. Based on in vivo studies, D4 and D6 derivatives exhibited the best pharmacological results, although only D6 showed a statistically significant difference compared to the control. Also, for D4 and D6 derivatives, myelin staining confirmed reduced degeneration in the corpus callosum. Consequently, D4 and D6 derivatives are promising candidates for developing new NMDA antagonists with therapeutic value against MS disorders.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"599-615"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies. 干粉吸入器设计与颗粒技术在提高肺部药物沉积方面的应用:挑战与未来战略。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-06-11 DOI: 10.1007/s40199-024-00520-3
Nazrul Islam, Tan Suwandecha, Teerapol Srichana

Objectives: The efficient delivery of drugs from dry powder inhaler (DPI) formulations is associated with the complex interaction between the device design, drug formulations, and patient's inspiratory forces. Several challenges such as limited emitted dose of drugs from the formulation, low and variable deposition of drugs into the deep lungs, are to be resolved for obtaining the efficiency in drug delivery from DPI formulations. The objective of this study is to review the current challenges of inhaled drug delivery technology and find a way to enhance the efficiency of drug delivery from DPIs.

Methods/evidence acquisition: Using appropriate keywords and phrases as search terms, evidence was collected from the published articles following SciFinder, Web of Science, PubMed and Google Scholar databases.

Results: Successful lung drug delivery from DPIs is very challenging due to the complex anatomy of the lungs and requires an integrated strategy for particle technology, formulation design, device design, and patient inhalation force. New DPIs are still being developed with limited performance and future device design employs computer simulation and engineering technology to overcome the ongoing challenges. Many issues of drug formulation challenges and particle technology are concerning factors associated with drug dispersion from the DPIs into deep lungs.

Conclusion: This review article addressed the appropriate design of DPI devices and drug formulations aligned with the patient's inhalation maneuver for efficient delivery of drugs from DPI formulations.

目标:干粉吸入器(DPI)配方的高效给药与设备设计、药物配方和患者吸力之间复杂的相互作用有关。要实现干粉吸入器配方的高效给药,需要解决一些难题,如配方的药物释放剂量有限、药物在肺深部的沉积量低且不稳定等。本研究的目的是回顾当前吸入给药技术面临的挑战,并找到提高干粉吸入器给药效率的方法:使用适当的关键词和短语作为搜索条件,从SciFinder、Web of Science、PubMed和Google Scholar数据库中已发表的文章中收集证据:由于肺部解剖结构复杂,DPIs 成功实现肺部给药非常具有挑战性,需要对颗粒技术、配方设计、设备设计和患者吸入力采取综合策略。目前正在开发的新型干粉吸入器性能有限,未来的设备设计将采用计算机模拟和工程技术来克服当前的挑战。药物配方挑战和微粒技术等许多问题都与药物从干粉吸入器分散到肺深部有关:这篇综述文章论述了如何根据患者的吸入动作设计适当的 DPI 装置和药物配方,以便从 DPI 配方中有效地输送药物。
{"title":"Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.","authors":"Nazrul Islam, Tan Suwandecha, Teerapol Srichana","doi":"10.1007/s40199-024-00520-3","DOIUrl":"10.1007/s40199-024-00520-3","url":null,"abstract":"<p><strong>Objectives: </strong>The efficient delivery of drugs from dry powder inhaler (DPI) formulations is associated with the complex interaction between the device design, drug formulations, and patient's inspiratory forces. Several challenges such as limited emitted dose of drugs from the formulation, low and variable deposition of drugs into the deep lungs, are to be resolved for obtaining the efficiency in drug delivery from DPI formulations. The objective of this study is to review the current challenges of inhaled drug delivery technology and find a way to enhance the efficiency of drug delivery from DPIs.</p><p><strong>Methods/evidence acquisition: </strong>Using appropriate keywords and phrases as search terms, evidence was collected from the published articles following SciFinder, Web of Science, PubMed and Google Scholar databases.</p><p><strong>Results: </strong>Successful lung drug delivery from DPIs is very challenging due to the complex anatomy of the lungs and requires an integrated strategy for particle technology, formulation design, device design, and patient inhalation force. New DPIs are still being developed with limited performance and future device design employs computer simulation and engineering technology to overcome the ongoing challenges. Many issues of drug formulation challenges and particle technology are concerning factors associated with drug dispersion from the DPIs into deep lungs.</p><p><strong>Conclusion: </strong>This review article addressed the appropriate design of DPI devices and drug formulations aligned with the patient's inhalation maneuver for efficient delivery of drugs from DPI formulations.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"761-779"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the relationship between inflammation and microbiota in the intestinal tissue of female and male rats fed with fructose: Modulatory role of metformin. 研究果糖喂养的雌性和雄性大鼠肠道组织中炎症与微生物群之间的关系:二甲双胍的调节作用
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-06-17 DOI: 10.1007/s40199-024-00521-2
Azimet Yalçın Buğdaycı, Saadet Özen Akarca Dizakar, Mürşide Ayşe Demirel, Suna Ömeroğlu, Fatma Akar, Mecit Orhan Uludağ

Background: It has been reported that High-Fructose (HF) consumption, considered one of the etiological factors of Metabolic Syndrome (MetS), causes changes in the gut microbiota and metabolic disorders. There is limited knowledge on the effects of metformin in HF-induced intestinal irregularities in male and female rats with MetS.

Objectives: In this study, we investigated the sex-dependent effects of metformin treatment on the gut microbiota, intestinal Tight Junction (TJ) proteins, and inflammation parameters in HF-induced MetS.

Methods: Fructose was given to the male and female rats as a 20% solution in drinking water for 15 weeks. Metformin (200 mg/kg) was administered by gastric tube once a day during the final seven weeks. Biochemical, histopathological, immunohistochemical, and bioinformatics analyses were performed. Differences were considered statistically significant at p < 0.05.

Results: The metformin treatment in fructose-fed rats promoted glucose, insulin, Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR), and Triglyceride (TG) values in both sexes. The inflammation score was significantly decreased with metformin treatment in fructose-fed male and female rats (p < 0.05). Moreover, metformin treatment significantly decreased Interleukin-1 Beta (IL-1β) and Tumor Necrosis Factor-Alpha (TNF-α) in ileum tissue from fructose-fed males (p < 0.05). Intestinal immunoreactivity of Occludin and Claudin-1 was increased with metformin treatment in fructose-fed female rats. HF and metformin treatment changed the gut microbial composition. Firmicutes/Bacteroidetes (F/B) ratio increased with HF in females. In the disease group, Bifidobacterium pseudolongum; in the treatment group, Lactobacillus helveticus and Lactobacillus reuteri are the prominent species in both sexes. When the male and female groups were compared, Akkermansia muciniphila was prominent in the male treatment group.

Conclusion: In conclusion, metformin treatment promoted biochemical parameters in both sexes of fructose-fed rats. Metformin showed a sex-dependent effect on inflammation parameters, permeability factors, and gut microbiota. Metformin has partly modulatory effects on fructose-induced intestinal changes.

背景:据报道,摄入高果糖(HF)被认为是代谢综合征(MetS)的病因之一,会导致肠道微生物群的变化和代谢紊乱。关于二甲双胍对 HF 诱导的代谢综合征雌雄大鼠肠道功能紊乱的影响,目前所知有限:本研究探讨了二甲双胍治疗对高频诱导 MetS 大鼠肠道微生物群、肠道 TJ 蛋白和炎症参数的性别依赖性影响:方法:将 20% 的果糖溶于饮用水中,给雌雄大鼠服用 15 周。在最后七周,每天一次通过胃管给药二甲双胍(200 毫克/千克)。对大鼠进行了生化、组织病理学、免疫组化和生物信息学分析。结果显示,二甲双胍治疗果蝇的结果与二甲双胍治疗果蝇的结果有显著统计学差异:二甲双胍治疗果糖喂养大鼠可提高雌雄大鼠的血糖、胰岛素、胰岛素抵抗指数稳态模型评估(HOMA-IR)和甘油三酯(TG)值。二甲双胍治疗后,果糖喂养的雄性和雌性大鼠的炎症评分均明显降低(p 结论:二甲双胍治疗对大鼠的炎症评分有促进作用:总之,二甲双胍治疗对果糖喂养大鼠的生化指标均有促进作用。二甲双胍对炎症参数、渗透因子和肠道微生物群的影响与性别有关。二甲双胍对果糖引起的肠道变化具有部分调节作用。
{"title":"Investigation of the relationship between inflammation and microbiota in the intestinal tissue of female and male rats fed with fructose: Modulatory role of metformin.","authors":"Azimet Yalçın Buğdaycı, Saadet Özen Akarca Dizakar, Mürşide Ayşe Demirel, Suna Ömeroğlu, Fatma Akar, Mecit Orhan Uludağ","doi":"10.1007/s40199-024-00521-2","DOIUrl":"10.1007/s40199-024-00521-2","url":null,"abstract":"<p><strong>Background: </strong>It has been reported that High-Fructose (HF) consumption, considered one of the etiological factors of Metabolic Syndrome (MetS), causes changes in the gut microbiota and metabolic disorders. There is limited knowledge on the effects of metformin in HF-induced intestinal irregularities in male and female rats with MetS.</p><p><strong>Objectives: </strong>In this study, we investigated the sex-dependent effects of metformin treatment on the gut microbiota, intestinal Tight Junction (TJ) proteins, and inflammation parameters in HF-induced MetS.</p><p><strong>Methods: </strong>Fructose was given to the male and female rats as a 20% solution in drinking water for 15 weeks. Metformin (200 mg/kg) was administered by gastric tube once a day during the final seven weeks. Biochemical, histopathological, immunohistochemical, and bioinformatics analyses were performed. Differences were considered statistically significant at p < 0.05.</p><p><strong>Results: </strong>The metformin treatment in fructose-fed rats promoted glucose, insulin, Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR), and Triglyceride (TG) values in both sexes. The inflammation score was significantly decreased with metformin treatment in fructose-fed male and female rats (p < 0.05). Moreover, metformin treatment significantly decreased Interleukin-1 Beta (IL-1β) and Tumor Necrosis Factor-Alpha (TNF-α) in ileum tissue from fructose-fed males (p < 0.05). Intestinal immunoreactivity of Occludin and Claudin-1 was increased with metformin treatment in fructose-fed female rats. HF and metformin treatment changed the gut microbial composition. Firmicutes/Bacteroidetes (F/B) ratio increased with HF in females. In the disease group, Bifidobacterium pseudolongum; in the treatment group, Lactobacillus helveticus and Lactobacillus reuteri are the prominent species in both sexes. When the male and female groups were compared, Akkermansia muciniphila was prominent in the male treatment group.</p><p><strong>Conclusion: </strong>In conclusion, metformin treatment promoted biochemical parameters in both sexes of fructose-fed rats. Metformin showed a sex-dependent effect on inflammation parameters, permeability factors, and gut microbiota. Metformin has partly modulatory effects on fructose-induced intestinal changes.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"515-535"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid management strategies for diabetic patients align with an evidence-based guideline. 糖尿病患者的血脂管理策略符合循证指南。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-09-06 DOI: 10.1007/s40199-024-00534-x
Mona Kargar, Noushid Zare, Aarefeh Jafarzadeh Kohneloo, Fatemeh Afra, Elham Hadidi, Kheirollah Gholami

Background: Diabetes mellitus (DM) increases the risk of cardiovascular diseases (CVD) significantly. Statins are recommended for all diabetic patients aged ≥ 40 years to alleviate this risk.

Objectives: This study aimed to determine the status of the implementation of the recommendations of lipid management strategies for diabetic patients.

Methods: In this cross-sectional study, 500 patients with DM, aged ≥ 40 referring to a public pharmacy with at least one diabetic medication in their prescription, were enrolled. Patients' demographics, lipid panel data, medications, personal and family history of atherosclerotic cardiovascular disease (ASCVD), and risk factors for ASCVD were documented. The appropriateness of stain dosing intensity was judged based on the American Diabetes Association (ADA) guideline.

Results: The mean ± SD of the age of patients was 61.39 ± 10.49 years. Among patients, 238 (47.6) were men. More than half of the patients were subject to receiving primary prevention (59.8%, n = 299). For 80.8% (n = 404) of patients, a statin, most frequently atorvastatin (61.8%), was prescribed. The appropriate statin dose based on the guideline for 470 patients (94%), was high-intensity statin. In 70.6% (n = 353) of patients, lipid management was not in accordance with the guideline. Patients with ASCVD were more likely to receive the statins and the appropriate doses compared to patients without ASCVD (p-value < 0.001).

Conclusion: Despite a relatively high percentage of patients who received statins, the lipid management in most patients was not in accordance with the guideline. The profound problem was the suboptimal dosage of statins. Investigating the reasons and barriers of the appropriate management can be helpful. Additionally, since patients without ASCVD who should receive statins for primary prevention were significantly less likely to receive statins and evidence-based doses, more attention is needed for this population.

背景:糖尿病(DM)会显著增加心血管疾病(CVD)的风险。建议所有年龄≥40 岁的糖尿病患者服用他汀类药物来降低这一风险:本研究旨在确定糖尿病患者血脂管理策略建议的实施情况:在这项横断面研究中,500 名年龄≥ 40 岁的糖尿病患者被纳入研究范围,他们在公共药房就诊,处方中至少有一种糖尿病药物。研究记录了患者的人口统计学特征、血脂组合数据、用药情况、个人和家族动脉粥样硬化性心血管疾病(ASCVD)病史以及 ASCVD 的危险因素。根据美国糖尿病协会(ADA)指南判断染色剂剂量强度是否合适:患者的平均年龄(61.39±10.49)岁。238 名患者(47.6%)为男性。一半以上的患者接受初级预防(59.8%,n = 299)。80.8%的患者(n = 404)处方了他汀类药物,最常见的是阿托伐他汀(61.8%)。根据指南,470 名患者(94%)的他汀类药物适当剂量为高强度他汀类药物。70.6%(353 人)的患者血脂管理不符合指南要求。与无 ASCVD 的患者相比,有 ASCVD 的患者更有可能接受他汀类药物和适当剂量的治疗(P 值 结论):尽管接受他汀类药物治疗的患者比例相对较高,但大多数患者的血脂管理并不符合指南要求。最严重的问题是他汀类药物的剂量不够理想。调查适当管理的原因和障碍会有所帮助。此外,由于应接受他汀类药物进行一级预防的无 ASCVD 患者接受他汀类药物和循证剂量的可能性明显较低,因此需要对这一人群给予更多关注。
{"title":"Lipid management strategies for diabetic patients align with an evidence-based guideline.","authors":"Mona Kargar, Noushid Zare, Aarefeh Jafarzadeh Kohneloo, Fatemeh Afra, Elham Hadidi, Kheirollah Gholami","doi":"10.1007/s40199-024-00534-x","DOIUrl":"10.1007/s40199-024-00534-x","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) increases the risk of cardiovascular diseases (CVD) significantly. Statins are recommended for all diabetic patients aged ≥ 40 years to alleviate this risk.</p><p><strong>Objectives: </strong>This study aimed to determine the status of the implementation of the recommendations of lipid management strategies for diabetic patients.</p><p><strong>Methods: </strong>In this cross-sectional study, 500 patients with DM, aged ≥ 40 referring to a public pharmacy with at least one diabetic medication in their prescription, were enrolled. Patients' demographics, lipid panel data, medications, personal and family history of atherosclerotic cardiovascular disease (ASCVD), and risk factors for ASCVD were documented. The appropriateness of stain dosing intensity was judged based on the American Diabetes Association (ADA) guideline.</p><p><strong>Results: </strong>The mean ± SD of the age of patients was 61.39 ± 10.49 years. Among patients, 238 (47.6) were men. More than half of the patients were subject to receiving primary prevention (59.8%, n = 299). For 80.8% (n = 404) of patients, a statin, most frequently atorvastatin (61.8%), was prescribed. The appropriate statin dose based on the guideline for 470 patients (94%), was high-intensity statin. In 70.6% (n = 353) of patients, lipid management was not in accordance with the guideline. Patients with ASCVD were more likely to receive the statins and the appropriate doses compared to patients without ASCVD (p-value < 0.001).</p><p><strong>Conclusion: </strong>Despite a relatively high percentage of patients who received statins, the lipid management in most patients was not in accordance with the guideline. The profound problem was the suboptimal dosage of statins. Investigating the reasons and barriers of the appropriate management can be helpful. Additionally, since patients without ASCVD who should receive statins for primary prevention were significantly less likely to receive statins and evidence-based doses, more attention is needed for this population.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"665-673"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence). 基于机器学习技术(人工智能)预测阿片类药物中毒时的纳洛酮剂量。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-05-21 DOI: 10.1007/s40199-024-00518-x
Seyed Ali Mohtarami, Babak Mostafazadeh, Shahin Shadnia, Mitra Rahimi, Peyman Erfan Talab Evini, Maral Ramezani, Hamed Borhany, Mobin Fathy, Hamidreza Eskandari

Background: Treatment management for opioid poisoning is critical and, at the same time, requires specialized knowledge and skills. This study was designed to develop and evaluate machine learning algorithms for predicting the maintenance dose and duration of hospital stay in opioid poisoning, in order to facilitate appropriate clinical decision-making.

Method and results: This study used artificial intelligence technology to predict the maintenance dose and duration of administration by selecting clinical and paraclinical features that were selected by Pearson correlation (filter method) (Stage 1) and then the (wrapper method) Recursive Feature Elimination Cross-Validated (RFECV) (Stage2). The duration of administration was divided into two categories: A (which includes a duration of less than or equal to 24 h of infusion) and B (more than 24 h of naloxone infusion). XGBoost algorithm model with an accuracy rate of 91.04%, a prediction rate of 91.34%, and a sensitivity rate of 91.04% and area under the Curve (AUC) 0.97 was best model for classification patients. Also, the best maintenance dose of naloxone was obtained with XGBoost algorithm with R2 = 0.678. Based on the selected algorithm, the most important features for classifying patients for the duration of treatment were bicarbonate, respiration rate, physical sign, The partial pressure of carbon dioxide (PCO2), diastolic blood pressure, pulse rate, naloxone bolus dose, Blood Creatinine(Cr), Body temperature (T). The most important characteristics for determining the maintenance dose of naloxone were physical signs, bolus dose of 4.5 mg/kg, Glasgow Coma Scale (GCS), Creatine Phosphokinase (CPK) and intensive care unit (ICU) add.

Conclusion: A predictive model can significantly enhance the decision-making and clinical care provided by emergency physicians in hospitals and medical settings. XGBoost was found to be the superior model.

背景:阿片类药物中毒的治疗管理至关重要,同时也需要专业知识和技能。本研究旨在开发和评估用于预测阿片类药物中毒的维持剂量和住院时间的机器学习算法,以促进适当的临床决策:本研究采用人工智能技术,通过皮尔逊相关法(过滤法)(第一阶段)和递归特征消除交叉验证法(RFECV)(第二阶段)选择临床和辅助临床特征,预测维持剂量和用药时间。施药时间分为两类:A(包括小于或等于 24 小时的输注时间)和 B(超过 24 小时的纳洛酮输注时间)。XGBoost 算法模型的准确率为 91.04%,预测率为 91.34%,灵敏度为 91.04%,曲线下面积(AUC)为 0.97,是对患者进行分类的最佳模型。此外,XGBoost 算法获得了纳洛酮的最佳维持剂量,R2 = 0.678。根据所选算法,对患者治疗时间长短进行分类的最重要特征是碳酸氢盐、呼吸频率、体征、二氧化碳分压(PCO2)、舒张压、脉搏、纳洛酮栓剂剂量、血肌酐(Cr)、体温(T)。确定纳洛酮维持剂量的最重要特征是体征、4.5 毫克/千克的栓塞剂量、格拉斯哥昏迷量表(GCS)、肌酸磷酸激酶(CPK)和重症监护室(ICU)加药量:预测模型可大大提高医院和医疗机构急诊医生的决策和临床护理水平。XGBoost 被认为是更优越的模型。
{"title":"Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence).","authors":"Seyed Ali Mohtarami, Babak Mostafazadeh, Shahin Shadnia, Mitra Rahimi, Peyman Erfan Talab Evini, Maral Ramezani, Hamed Borhany, Mobin Fathy, Hamidreza Eskandari","doi":"10.1007/s40199-024-00518-x","DOIUrl":"10.1007/s40199-024-00518-x","url":null,"abstract":"<p><strong>Background: </strong>Treatment management for opioid poisoning is critical and, at the same time, requires specialized knowledge and skills. This study was designed to develop and evaluate machine learning algorithms for predicting the maintenance dose and duration of hospital stay in opioid poisoning, in order to facilitate appropriate clinical decision-making.</p><p><strong>Method and results: </strong>This study used artificial intelligence technology to predict the maintenance dose and duration of administration by selecting clinical and paraclinical features that were selected by Pearson correlation (filter method) (Stage 1) and then the (wrapper method) Recursive Feature Elimination Cross-Validated (RFECV) (Stage2). The duration of administration was divided into two categories: A (which includes a duration of less than or equal to 24 h of infusion) and B (more than 24 h of naloxone infusion). XGBoost algorithm model with an accuracy rate of 91.04%, a prediction rate of 91.34%, and a sensitivity rate of 91.04% and area under the Curve (AUC) 0.97 was best model for classification patients. Also, the best maintenance dose of naloxone was obtained with XGBoost algorithm with R<sup>2</sup> = 0.678. Based on the selected algorithm, the most important features for classifying patients for the duration of treatment were bicarbonate, respiration rate, physical sign, The partial pressure of carbon dioxide (PCO<sub>2</sub>), diastolic blood pressure, pulse rate, naloxone bolus dose, Blood Creatinine(Cr), Body temperature (T). The most important characteristics for determining the maintenance dose of naloxone were physical signs, bolus dose of 4.5 mg/kg, Glasgow Coma Scale (GCS), Creatine Phosphokinase (CPK) and intensive care unit (ICU) add.</p><p><strong>Conclusion: </strong>A predictive model can significantly enhance the decision-making and clinical care provided by emergency physicians in hospitals and medical settings. XGBoost was found to be the superior model.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"495-513"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-pot synthesis of polysaccharide/gelatin amorphous hydrogels impregnated with a bioflavonoid derived from Elaeis guineensis leaf: wound healing and drug release properties. 多糖/明胶无定形水凝胶的一锅合成:伤口愈合和药物释放特性。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 Epub Date: 2024-09-28 DOI: 10.1007/s40199-024-00540-z
Mohamad Shazeli Che Zain, Mohammed Danish, Khozirah Shaari, Sharida Fakurazi

Background: Amorphous hydrogel is a strategic wound healing dressings that comprised of water, polymers and excipients with no shape. The dense cross-linked network of polymer is interspersed by the immobilized water component could rehydrate and promote healing in wound tissue.

Objective: In this work, various polysaccharide/gelatin amorphous hydrogels with the impregnation of oil palm leaf derived total flavonoid enriched extract (OPL-TFEE) were fabricated via one-pot synthesis method to provide multiple crosslinking networks.

Method: The bioflavonoids (OPL-TFEE) were derived from Elaeis guineensis leaf using an integrated green extraction and enrichment process. Amorphous hydrogels with good wound healing properties were developed by incorporating 0.3% antioxidant agent into the hybrid polymeric gelling system.

Result: The formulations appeared as a semi-solid dark yellow translucent hydrogel with good spreading and consistency characteristics and satisfying aesthetic properties. The FTIR analysis indicated that the bioflavonoid was compatible with the matrix, and the hydrogels showed porous morphological structures when observed under SEM. Furthermore, the hydrogels possessed shear thinning, pseudoplastic, and elastic properties. Bioflavonoids-impregnated polysaccharide/gelatin hydrogel release 95-98% bioflavonoids within 24 h, while the drug release profile followed the Korsmeyer-Peppas kinetic model. The hydrogels showed antioxidant and wound healing properties with no sign of cytotoxicity.

Conclusion: Overall, the results revealed bioflavonoid-loaded hydrogels exhibited good physicochemical and biological properties, thus could serve as new innovative formulation in the sustainable advancement of wound care product for promoting wound healing.

背景:无定形水凝胶是一种战略性伤口愈合敷料,由水、聚合物和辅料组成,没有形状。聚合物的致密交联网络中夹杂着固定的水成分,可为伤口组织补充水分并促进愈合:本研究通过一锅合成法制备了浸渍油棕叶总黄酮富集提取物(OPL-TFEE)的各种多糖/明胶无定形水凝胶,以提供多重交联网络:方法:生物类黄酮(OPL-TFEE)来自油棕叶,采用绿色提取和富集一体化工艺。在混合聚合物胶凝体系中加入 0.3% 的抗氧化剂,开发出具有良好伤口愈合性能的无定形水凝胶:结果:配方呈半固态深黄色半透明水凝胶,具有良好的铺展性和稠度特性,并具有令人满意的美观特性。傅立叶变换红外分析表明,生物类黄酮与基质相容,在扫描电镜下观察,水凝胶呈现多孔形态结构。此外,水凝胶还具有剪切稀化、假塑性和弹性特性。浸渍生物类黄酮的多糖/明胶水凝胶可在 24 小时内释放 95-98% 的生物类黄酮,药物释放曲线遵循 Korsmeyer-Peppas 动力学模型。水凝胶具有抗氧化和伤口愈合特性,且无细胞毒性迹象:总之,研究结果表明,负载生物类黄酮的水凝胶具有良好的物理化学和生物学特性,因此可作为一种新型创新配方,用于促进伤口愈合的伤口护理产品的可持续发展。
{"title":"One-pot synthesis of polysaccharide/gelatin amorphous hydrogels impregnated with a bioflavonoid derived from Elaeis guineensis leaf: wound healing and drug release properties.","authors":"Mohamad Shazeli Che Zain, Mohammed Danish, Khozirah Shaari, Sharida Fakurazi","doi":"10.1007/s40199-024-00540-z","DOIUrl":"10.1007/s40199-024-00540-z","url":null,"abstract":"<p><strong>Background: </strong>Amorphous hydrogel is a strategic wound healing dressings that comprised of water, polymers and excipients with no shape. The dense cross-linked network of polymer is interspersed by the immobilized water component could rehydrate and promote healing in wound tissue.</p><p><strong>Objective: </strong>In this work, various polysaccharide/gelatin amorphous hydrogels with the impregnation of oil palm leaf derived total flavonoid enriched extract (OPL-TFEE) were fabricated via one-pot synthesis method to provide multiple crosslinking networks.</p><p><strong>Method: </strong>The bioflavonoids (OPL-TFEE) were derived from Elaeis guineensis leaf using an integrated green extraction and enrichment process. Amorphous hydrogels with good wound healing properties were developed by incorporating 0.3% antioxidant agent into the hybrid polymeric gelling system.</p><p><strong>Result: </strong>The formulations appeared as a semi-solid dark yellow translucent hydrogel with good spreading and consistency characteristics and satisfying aesthetic properties. The FTIR analysis indicated that the bioflavonoid was compatible with the matrix, and the hydrogels showed porous morphological structures when observed under SEM. Furthermore, the hydrogels possessed shear thinning, pseudoplastic, and elastic properties. Bioflavonoids-impregnated polysaccharide/gelatin hydrogel release 95-98% bioflavonoids within 24 h, while the drug release profile followed the Korsmeyer-Peppas kinetic model. The hydrogels showed antioxidant and wound healing properties with no sign of cytotoxicity.</p><p><strong>Conclusion: </strong>Overall, the results revealed bioflavonoid-loaded hydrogels exhibited good physicochemical and biological properties, thus could serve as new innovative formulation in the sustainable advancement of wound care product for promoting wound healing.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"689-703"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142343310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
DARU Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1